Drugs / SCTV02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06754605 | Feb 2025 → Jul 2027 expected | respiratory syncytial virus infectious disease | Sinocelltech Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCTV02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06754605 ↗ |
| Modality | Vaccine | “Recombinant Respiratory Syncytial Virus Vaccine (SCTV02)” NCT06754605 ↗ |